Massimo Crapis
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 7
- Antifungal resistance and susceptibility 2
- Epidemiology 15
- Infective Endocarditis Diagnosis and Management 7
- Pneumonia and Respiratory Infections 2
- Co-authors
- Pierluigi Viale (8 shared papers)Federico Pea (5 shared papers)Camilla Negri (3 shared papers)Francesco Cristini (3 shared papers)Mario Furlanut (2 shared papers)Assunta Sartor (4 shared papers)Marco Falcone (3 shared papers)Manuela Avolio (10 shared papers)
- Journals
- International Journal of Antimicrobial Agents (4 papers)Infection (2 papers)Future Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Expert Review of Anti-infective Therapy (1 paper)
- Partner nations
- ItalyUnited StatesVietnam
In The Last Decade
Massimo Crapis
30 papers receiving 609 citations
Peers
Comparison fields: 5 of 58
- Applied Microbiology and Biotechnology 39
- Molecular Medicine 103
- Infectious Diseases 202
- Epidemiology 287
- Clinical Biochemistry 59
Countries citing papers authored by Massimo Crapis
This map shows the geographic impact of Massimo Crapis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Crapis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Crapis more than expected).
Fields of papers citing papers by Massimo Crapis
This network shows the impact of papers produced by Massimo Crapis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Crapis. The network helps show where Massimo Crapis may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Crapis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 122 | |
| 2 | 2009 | 98 | |
| 3 | 2014 | 73 | |
| 4 | 2016 | 58 | |
| 5 | 2017 | 39 | |
| 6 | 2016 | 37 | |
| 7 | 2008 | 32 | |
| 8 | 2008 | 27 | |
| 9 | 2006 | 23 | |
| 10 | 2022 | 14 | |
| 11 | 2008 | 13 | |
| 12 | 2013 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2014 | 7 | |
| 16 | 2006 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2024 | 3 |
About Massimo Crapis
Massimo Crapis is a scholar working on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Pharmacology and Clinical Biochemistry, having authored 35 papers that have together received 617 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (7 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers), Antibiotic Resistance in Bacteria (4 papers), Antifungal resistance and susceptibility (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (39 citations), Molecular Medicine (103 citations), Infectious Diseases (202 citations), Epidemiology (287 citations) and Clinical Biochemistry (59 citations). Massimo Crapis has collaborated with scholars based in Italy, United States and Vietnam. Frequent co-authors include Pierluigi Viale, Federico Pea, Camilla Negri, Francesco Cristini, Mario Furlanut, Assunta Sartor, Marco Falcone, Manuela Avolio, Emanuele Durante‐Mangoni and Claudio Scarparo. Their work appears in journals such as International Journal of Antimicrobial Agents, Infection, Future Microbiology, Antimicrobial Agents and Chemotherapy and Expert Review of Anti-infective Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.